Naveen Yalamanchi serves as a Partner and Portfolio Manager at RTW Investments, a leading life sciences investment and innovation firm dedicated to advancing transformative healthcare solutions. With a deep passion for fostering medical breakthroughs, Naveen plays a pivotal role in identifying, investing in, and supporting cutting-edge biotechnology and pharmaceutical ventures that have the potential to address unmet medical needs.
In addition to his work with RTW, Naveen is the Co-Founder and a Director of Rocket Pharmaceuticals, a fully integrated, clinical-stage biotechnology company pioneering gene therapy solutions for rare and devastating diseases. Rocket Pharmaceuticals focuses on developing potentially curative, first-in-class therapies, leveraging innovative scientific approaches to transform the lives of patients and families affected by genetic disorders.
Naveen’s dual roles reflect his commitment to bridging scientific discovery with strategic investment, ensuring that groundbreaking therapies reach patients in need. His work has been instrumental in advancing the development of novel medical treatments, driving innovation in the life sciences sector, and building a legacy of impact in the global healthcare community.
